Recombinant Proteins of Therapeutic Interest Expressed by Lymphoid Cell Lines Derived from Transgenic Mice
- 1 October 1989
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 7 (10) , 1049-1054
- https://doi.org/10.1038/nbt1089-1049
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pancreatic Neoplasia Induced by SV40 T-Antigen Expression in Acinar Cells of Transgenic MiceScience, 1987
- Transgenic Mice with Immunoglobulin GenesAnnual Review of Immunology, 1987
- Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.Journal of Clinical Investigation, 1986
- Transhybridomas from fusion gene transgenic lymphocytes can be used to produce foreign protein of biological interestEuropean Journal of Immunology, 1986
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985
- Active γ-carboxylated human factor IX expressed using recombinant DNA techniquesNature, 1985
- Mutation of Antitrypsin to AntithrombinNew England Journal of Medicine, 1983
- A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genesCell, 1983
- A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain geneCell, 1983
- Functional significance and evolutionary development of the 5′-terminal regions of immunoglobulin variable-region genesCell, 1982